InvestorsHub Logo
Followers 110
Posts 6480
Boards Moderated 0
Alias Born 05/01/2003

Re: None

Friday, 01/07/2011 6:01:10 PM

Friday, January 07, 2011 6:01:10 PM

Post# of 92948
rumit,

This is the "something" I wanted to check out.

License agreements with both Wicell and WARF appear in the 2008 10K
but neither are listed in 2009 10K. I have checked and re-checked rumit, it appears for now we may have breached and lost those agreements due to the info below.

I posted this as NEW back in July 2009,

"We are not in full compliance with some of our license agreements. We are not in full compliance with some of our licenses (see Our Intellectual Property in the BUSINESS section of this 10k) and due to limited financial resources we cannot guarantee that we will regain full compliance status." http://investorshub.advfn.com/boards/read_msg.aspx?message_id=39323481

(page 15) WiCell 2002 License
We are currently behind on our payments of the license fees, since 2008, and as such we are in breach of the license agreemen
http://www.sec.gov/Archives/edgar/data/1140098/000114420409036193/v154150_10k.htm

I checked for prior year(2008)10K and they were listed.

WiCell 2002 License - In March 2002, we entered into an industry research license and material transfer agreement (indefinite license period) with WiCell Research Institute, Inc., referred to as WiCell, pursuant to which WiCell granted to us a non-exclusive license, with no right to sublicense, to make, use and sell or otherwise transfer certain primate embryonic stem cells and derivatives thereof for internal research purposes and to receive such primate embryonic stem cells or derivatives from third parties for internal research purposes. In consideration of the license granted to us by WiCell, we agreed to pay a license fee of $100,000 and an annual maintenance fee of $25,000. The license includes a grant from us to WiCell of a non-exclusive, royalty-free, irrevocable, paid-up research license under any inventions made by or for us to the extent that such inventions are a modification of an invention described in the licensed patent rights. We are currently behind on our payments of the license fees, since 2008, and as such we are in breach of the license agreement.

WARF and WiCell 2007 License - On May 2, 2007, we entered into a commercial products addendum (indefinite period) with the Wisconsin Alumni Research Foundation ("WARF") and its subsidiary, WiCell Research Institute, Inc., ("WiCell"). The addendum amends in certain respects the industry research license and material transfer agreement discussed above. The addendum (i) grants to us a non-exclusive, world-wide commercial license to 23 issued patents and 123 patents pending to pursue therapeutic and research products utilizing human embryonic stem cell technology and (ii) provides for certain sublicensing rights to enable us to further the development and commercialization of products. The addendum requires us to make certain royalty payments and pay license fees to WARF as set forth in the addendum. The maintenance fees required under the 2002 WiCell License are waived during the term of the 2007 License.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.